NO20030870L - Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav - Google Patents

Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav

Info

Publication number: NO20030870L
Authority: NO; Norway
Prior art keywords: preparation; drugs containing; bicyclic heterocycles; heterocycles; bicyclic
Prior art date: 2000-08-26

Application number

NO20030870A

Other languages

English (en)

Other versions

NO324866B1 (no

NO20030870D0 (no

Inventor

Frank Himmelsbach

Elke Langkopf

Birgit Jung

Stefan Blech

Flavio Solca

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-26

Filing date

2003-02-25

Publication date

2003-02-25

2003-02-25 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-02-25 Publication of NO20030870L publication Critical patent/NO20030870L/no

2003-02-25 Publication of NO20030870D0 publication Critical patent/NO20030870D0/no

2007-12-17 Publication of NO324866B1 publication Critical patent/NO324866B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Immunology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20030870A 2000-08-26 2003-02-25 Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelse for fremstilling av legemidler for behandling av sykdommer og fremgangsmater for fremstilling derav NO324866B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10042058A DE10042058A1 (de)	2000-08-26	2000-08-26	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP2001/009532 WO2002018351A1 (de)	2000-08-26	2001-08-18	Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und vefahren zu ihrer herstellung

Publications (3)

Publication Number	Publication Date
NO20030870L true NO20030870L (no)	2003-02-25
NO20030870D0 NO20030870D0 (no)	2003-02-25
NO324866B1 NO324866B1 (no)	2007-12-17

Family

ID=7653945

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20030870A NO324866B1 (no)	2000-08-26	2003-02-25	Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelse for fremstilling av legemidler for behandling av sykdommer og fremgangsmater for fremstilling derav

Country Status (30)

Country	Link
EP (1)	EP1315705A1 (no)
JP (1)	JP4834282B2 (no)
KR (1)	KR100862873B1 (no)
CN (1)	CN100404517C (no)
AR (1)	AR033562A1 (no)
AU (2)	AU2001287694B2 (no)
BG (1)	BG107559A (no)
BR (1)	BR0113519A (no)
CA (1)	CA2417897C (no)
CZ (1)	CZ302567B6 (no)
DE (1)	DE10042058A1 (no)
EA (1)	EA005679B1 (no)
EC (1)	ECSP034464A (no)
EE (1)	EE05269B1 (no)
HR (1)	HRP20030138A2 (no)
HU (1)	HUP0300819A3 (no)
IL (2)	IL154602A0 (no)
ME (1)	MEP58708A (no)
MX (1)	MXPA03001483A (no)
MY (1)	MY126132A (no)
NO (1)	NO324866B1 (no)
NZ (1)	NZ524668A (no)
PL (1)	PL360248A1 (no)
RS (1)	RS52279B (no)
SK (1)	SK287747B6 (no)
TW (1)	TWI294422B (no)
UA (1)	UA73004C2 (no)
UY (1)	UY26903A1 (no)
WO (1)	WO2002018351A1 (no)
ZA (1)	ZA200300991B (no)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA01012899A (es)	1999-06-21	2002-07-30	Boehringer Ingelheim Pharma	Heterociclos biciclicos, medicamentos que contienen estos compuestos, su empleo y procedimientos para su preparacion.
DE10042059A1 (de) *	2000-08-26	2002-03-07	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
TW200813014A (en) *	2002-03-28	2008-03-16	Astrazeneca Ab	Quinazoline derivatives
DE10214412A1 (de) *	2002-03-30	2003-10-09	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
MXPA04009536A (es) *	2002-03-30	2005-01-25	Boehringer Ingelheim Pharma	Compuestos heterociclos biciclicos, composiciones farmaceuticas que contienen estos compuestos, su utilizacion y procesos para su preparacion.
US7576074B2 (en)	2002-07-15	2009-08-18	Rice Kenneth D	Receptor-type kinase modulators and methods of use
DE10326186A1 (de)	2003-06-06	2004-12-23	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE10334226A1 (de) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
ES2305844T3 (es)	2003-09-16	2008-11-01	Astrazeneca Ab	Derivados de quinazolina como inhibidores de tirosina cinasa.
DE602004004553T2 (de)	2003-09-19	2007-10-25	Astrazeneca Ab	Chinazolinderivate
PL2392565T3 (pl)	2003-09-26	2014-08-29	Exelixis Inc	Modulatory c-Met i sposoby stosowania
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10345875A1 (de) *	2003-09-30	2005-04-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Vewendung und Verfahren zu ihrer Herstellung
DE10350717A1 (de) *	2003-10-30	2005-06-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verwendung von Tyrosinkinase-Inhibitoren zur Behandlung inflammatorischer Prozesse
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
JP5054544B2 (ja)	2005-02-26	2012-10-24	アストラゼネカアクチボラグ	チロシンキナーゼ阻害剤としてのキナゾリン誘導体
KR100673775B1 (ko) *	2005-04-08	2007-01-24	엘지전자 주식회사	냉장고용 홈바
CA2619037A1 (en) *	2005-08-22	2007-03-01	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof
CA2833706C (en)	2005-11-11	2014-10-21	Boehringer Ingelheim International Gmbh	Quinazoline derivatives for the treatment of cancer diseases
CA2643363A1 (en) *	2006-03-09	2007-09-13	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
RU2492864C2 (ru)	2006-09-18	2013-09-20	Бёрингер Ингельхайм Интернациональ Гмбх	Способ лечения рака, несущего мутации egfr
EP1921070A1 (de)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
US7998949B2 (en)	2007-02-06	2011-08-16	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
BRPI0907916A2 (pt)	2008-02-07	2015-07-28	Boehringer Ingelheim Int	Heterociclos espirociclos, medicamentos contendo esses compostos, e processos para preparar os mesmos
WO2009138781A1 (en)	2008-05-13	2009-11-19	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
TW201920110A (zh)	2009-01-16	2019-06-01	美商艾克塞里克斯公司	包含n-(4-{[6,7-雙(甲氧基)喹啉-4-基]氧基}苯基)-n'-(4-氟苯基)環丙烷-1,1-二甲醯胺之蘋果酸鹽之醫藥組合物及其用途
LT2451445T (lt)	2009-07-06	2019-06-25	Boehringer Ingelheim International Gmbh	Bibw2992, jo druskų ir kietų farmacinių kompozicijų, apimančių šį aktyvųjį ingredientą, džiovinimo būdas
UA108618C2 (uk)	2009-08-07	2015-05-25		Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
KR101317809B1 (ko)	2011-06-07	2013-10-16	한미약품 주식회사	암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko)	2013-01-28	2014-08-06	한미약품 주식회사	1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
BR112015020787B1 (pt)	2013-03-06	2022-12-06	Astrazeneca Ab	Compostos 4-(substituído-anilino)-6-o-(substituídopiperizina-carbonil)quinazolínicos, seus sais, composição farmacêutica, uso e combinação
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
DK3126354T3 (da) *	2014-04-04	2020-03-09	H Lundbeck As	Halogenerede quinazolin-thf-aminer som pde1-inhibitorer
US20170176028A1 (en)	2015-12-18	2017-06-22	Lg Electronics Inc.	Air conditioner
CN110291104B (zh)	2016-11-17	2023-11-03	得克萨斯州大学系统董事会	具有针对携带egfr或her2外显子20突变之癌细胞的抗肿瘤活性的化合物
CN112321814B (zh) *	2020-12-30	2021-03-23	广州初曲科技有限公司	一种吉非替尼艾地苯醌轭合物的制备及用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9508538D0 (en) *	1995-04-27	1995-06-14	Zeneca Ltd	Quinazoline derivatives
GB9624482D0 (en) *	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
BR9707495A (pt) *	1996-02-13	1999-07-27	Zeneca Ltd	Derivado de quinazolina processo para a preparação do mesmo composição farmacêutica e processo para a produç o de um efeito antiangiogênico e/ou de redução de permeabilidade vascular em um animal de sangue quente
GB9603095D0 (en) *	1996-02-14	1996-04-10	Zeneca Ltd	Quinazoline derivatives
AU719327B2 (en) *	1996-03-05	2000-05-04	Astrazeneca Ab	4-anilinoquinazoline derivatives
NZ332119A (en) *	1996-04-12	2001-08-31	Warner Lambert Co	Quinazoline compounds which are irreversible inhibitors of tyrosine kinases
GB9718972D0 (en) *	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
DE19911509A1 (de) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung

2000
- 2000-08-26 DE DE10042058A patent/DE10042058A1/de not_active Ceased
2001
- 2001-08-18 AU AU2001287694A patent/AU2001287694B2/en not_active Ceased
- 2001-08-18 EA EA200300219A patent/EA005679B1/ru not_active IP Right Cessation
- 2001-08-18 NZ NZ524668A patent/NZ524668A/en not_active IP Right Cessation
- 2001-08-18 CA CA002417897A patent/CA2417897C/en not_active Expired - Fee Related
- 2001-08-18 AU AU8769401A patent/AU8769401A/xx active Pending
- 2001-08-18 EE EEP200300077A patent/EE05269B1/xx not_active IP Right Cessation
- 2001-08-18 SK SK231-2003A patent/SK287747B6/sk not_active IP Right Cessation
- 2001-08-18 PL PL36024801A patent/PL360248A1/xx not_active Application Discontinuation
- 2001-08-18 IL IL15460201A patent/IL154602A0/xx unknown
- 2001-08-18 HU HU0300819A patent/HUP0300819A3/hu unknown
- 2001-08-18 JP JP2002523469A patent/JP4834282B2/ja not_active Expired - Fee Related
- 2001-08-18 WO PCT/EP2001/009532 patent/WO2002018351A1/de not_active Ceased
- 2001-08-18 BR BR0113519-8A patent/BR0113519A/pt not_active Application Discontinuation
- 2001-08-18 EP EP01967285A patent/EP1315705A1/de not_active Ceased
- 2001-08-18 KR KR1020037002744A patent/KR100862873B1/ko not_active Expired - Fee Related
- 2001-08-18 CN CNB01814635XA patent/CN100404517C/zh not_active Expired - Fee Related
- 2001-08-18 CZ CZ20030870A patent/CZ302567B6/cs not_active IP Right Cessation
- 2001-08-18 RS YU14003A patent/RS52279B/sr unknown
- 2001-08-18 MX MXPA03001483A patent/MXPA03001483A/es active IP Right Grant
- 2001-08-18 ME MEP-587/08A patent/MEP58708A/xx unknown
- 2001-08-18 UA UA2003032533A patent/UA73004C2/uk unknown
- 2001-08-18 HR HR20030138A patent/HRP20030138A2/hr not_active Application Discontinuation
- 2001-08-23 UY UY26903A patent/UY26903A1/es not_active Application Discontinuation
- 2001-08-24 AR ARP010104041A patent/AR033562A1/es unknown
- 2001-08-24 MY MYPI20013985A patent/MY126132A/en unknown
- 2001-08-24 TW TW090120905A patent/TWI294422B/zh not_active IP Right Cessation
2003
- 2003-02-03 EC EC2003004464A patent/ECSP034464A/es unknown
- 2003-02-05 ZA ZA200300991A patent/ZA200300991B/en unknown
- 2003-02-14 BG BG107559A patent/BG107559A/bg unknown
- 2003-02-24 IL IL154602A patent/IL154602A/en not_active IP Right Cessation
- 2003-02-25 NO NO20030870A patent/NO324866B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2417897C (en)	2009-03-31
MY126132A (en)	2006-09-29
CN1449390A (zh)	2003-10-15
PL360248A1 (en)	2004-09-06
SK287747B6 (sk)	2011-08-04
NO324866B1 (no)	2007-12-17
HUP0300819A2 (hu)	2003-09-29
AU8769401A (en)	2002-03-13
CA2417897A1 (en)	2003-01-30
AU2001287694B2 (en)	2007-09-06
HUP0300819A3 (en)	2008-03-28
CN100404517C (zh)	2008-07-23
EE05269B1 (et)	2010-02-15
YU14003A (sh)	2006-01-16
MXPA03001483A (es)	2003-06-06
UA73004C2 (uk)	2005-05-16
EP1315705A1 (de)	2003-06-04
ZA200300991B (en)	2004-04-16
BR0113519A (pt)	2003-07-01
IL154602A (en)	2008-07-08
UY26903A1 (es)	2002-03-22
NZ524668A (en)	2006-06-30
HRP20030138A2 (en)	2005-04-30
KR100862873B1 (ko)	2008-10-15
IL154602A0 (en)	2003-09-17
MEP58708A (en)	2011-05-10
HK1057557A1 (zh)	2004-04-08
ECSP034464A (es)	2003-03-31
JP2004507529A (ja)	2004-03-11
JP4834282B2 (ja)	2011-12-14
CZ302567B6 (cs)	2011-07-13
EA005679B1 (ru)	2005-04-28
SK2312003A3 (en)	2003-10-07
EE200300077A (et)	2004-12-15
AR033562A1 (es)	2003-12-26
WO2002018351A1 (de)	2002-03-07
EA200300219A1 (ru)	2003-08-28
NO20030870D0 (no)	2003-02-25
KR20030024914A (ko)	2003-03-26
TWI294422B (en)	2008-03-11
DE10042058A1 (de)	2002-03-07
BG107559A (bg)	2003-10-31
RS52279B (sr)	2012-10-31

Publication	Publication Date	Title
NO20030870D0 (no)	2003-02-25	Bicykliske heterocykler, medikamenter inneholdende disse, deres anvendelseog fremgansgmåte for fremstilling derav
NO20016185D0 (no)	2001-12-18	Bicykliske heterocykler, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstillingderav
NO20032726D0 (no)	2003-06-16	Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
DK0966454T3 (da)	2003-09-01	Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
DE60100313D1 (de)	2003-07-03	Freisetzungssystem von Cyclopropenderivaten
NO20032735L (no)	2003-08-06	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene samt deres anvendelse
NO20040469L (no)	2004-04-30	Heterocykliske forbindelser samt fremstilling og anvendelse derav
NO20032733L (no)	2003-08-14	Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
DK1112251T3 (da)	2003-09-01	Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater
DE60115418D1 (de)	2006-01-05	Mikroinfusionsvorrichtung zur verabreichung von medikamenten
CY2007029I2 (el)	2009-11-04	Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
EE05387B1 (et)	2011-02-15	KinasoliiniÁderivaadid,ÁnendeÁvalmistamismeetodÁjaÁkasutamine
FI7846U1 (fi)	2008-04-28	Farmaseuttinen valmiste, joka sisältää oksikodonia ja naloksonia
AU2001287694A1 (en)	2002-06-06	Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
NO20032187D0 (no)	2003-05-14	Heterocyklylalkylpiperidinderivater, deres fremstilling samt preparater inneholdende forbindelsene
DK1128831T3 (da)	2005-01-17	Farmaceutisk moxifloxacinpræparat
DK1098874T3 (da)	2003-10-06	Benzocycloheptener, fremgangsmåder til deres fremstilling, farmaceutiske præparater, som indeholder disse, samt deres anvendelse til fremstilling af lægemidler
NO20022021D0 (no)	2002-04-29	Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
NO20016404L (no)	2002-03-01	Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
NO20024105L (no)	2002-10-28	Memnopeptider, fremgangsmåte for deres fremstilling og anvendelse av disse
DK1176148T3 (da)	2004-01-05	Benzothiadiazinforbindelser, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende disse
DK1341758T3 (da)	2006-10-30	Coniosetin og derivater af denne, fremgangsmåde til fremstilling og anvendelse af samme
NO20054130D0 (no)	2005-09-06	Kvaterne chelidonin- og alkaloidderivater, fremgangsmate for fremstilling av samme, samt anvendelse av disse for fremstilling av medikamenter
HU0200306D0 (en)	2002-04-29	Method for preparation of absorbent article, the absorbent article and application of it
DE60214533D1 (de)	2006-10-19	Pyridoindolonderivate und antikrebsmittel enthaltende pharmazeutische mischungen

Legal Events

Date	Code	Title	Description
2013-03-25	MM1K	Lapsed by not paying the annual fees